Recently, increasing evidence has suggested that NT-proBNP, an established biomarker for the diagnosis and prognosis of heart failure, is associated with the risk of incident diabetes (27, 28) and diabetes-related microvascular and macrovascular complications (29). The gene discussed is NPPB; the disease is diabetes mellitus.